Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Yes—Neuralink is one of several companies working on brain-computer interfaces (BCIs). Others include Synchron, Blackrock Neurotech, Paradromics, Precision Neuroscience and Science Corporation, alongside non-invasive EEG companies such as Neurable, OpenBCI and Muse. They are pursuing different technologies and applications, and their products are at very different stages: an investigational implant is not a product you can buy, while a consumer EEG wearable is not an equivalent to an implanted clinical BCI.
Why “BCI company” can mean very different things
A BCI records or acts on signals associated with the brain to enable a device or system to perform a task. That broad label covers markedly different approaches. Some systems place electrodes in or on the brain; others access signals through blood vessels, work with the visual system, or record electrical activity from the scalp. Their intended uses and evidence are different, too.
For a useful comparison, look at four things: how the system accesses signals, who it is intended to help, what evidence or regulatory milestone has been reported, and whether it is actually available in a particular country. A company announcement, a registered or authorized clinical study, and commercial availability are not interchangeable milestones.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Implantable and clinical BCI developers
| Company | Approach | Purpose and reported stage |
|---|---|---|
| Synchron | Endovascular: an interface delivered through blood vessels rather than directly implanted on the brain’s cortical surface. | A 2025 policy report identifies Synchron as an implantable BCI developer. The cited report does not state a specific regulatory or commercial status. |
| Blackrock Neurotech | Implantable BCI research and patient platform. | Blackrock describes a long-running human research platform. The company reports 19+ years of human studies, use at 1,000+ research institutions and 2,000+ published studies; these are company figures, accessed in 2026, not independent comparisons of performance. |
| Paradromics | Connexus uses a high-density implanted microelectrode array. The company says signals pass to a chest transceiver and then wirelessly to an external receiver. | Connect-One is intended to evaluate speech restoration and computer control for people with severe motor impairment. Paradromics announced IDE authorization in November 2025 and its first clinical implantation on June 17, 2026. Connexus is investigational and not for sale. |
| Precision Neuroscience | Layer 7 is a cortical interface, which the company describes as intended to help people with paralysis operate digital devices. | The company says the interface has FDA clearance, while also describing its BCI as investigational and unavailable for sale in the United States. The specific clearance should not be read as general approval of the BCI treatment system or as commercial availability. |
| Science Corporation | Its PRIMA retinal visual prosthesis is described by the company as a BCI vision-restoration technology. | This is a vision-restoration application, not a system for decoding motor intent to control a computer. The company reported a European commercial launch in July 2026 and says product regulatory status and availability vary by country. |
What the clinical milestones mean
Paradromics’ IDE authorization allowed the company to proceed with its study; it does not mean Connexus is an FDA-approved product. Likewise, a first clinical implantation marks a study milestone, not proof that a system is effective for every patient or ready for routine care. The Connect-One principal investigator, David M. Brandman, said the study would evaluate the technology “in a rigorous clinical setting” and help clarify its potential to restore communication.
#1 Best Overall
Precision Neuroscience’s statements illustrate why regulatory claims need to be read at the device and use level. The company’s claim that its interface has FDA clearance sits alongside its statement that its BCI application is investigational and not for sale in the United States. Those statements describe distinct claims and should not be compressed into “the BCI is FDA-approved.”
Non-invasive EEG and consumer neurotechnology
Neurable, OpenBCI and Muse are among the companies identified in a 2025 policy report as active outside the implant space. This part of the ecosystem includes EEG neuroheadsets and consumer wearables that measure electrical activity from the scalp. They can be relevant to consumer neurotechnology, research or wellness uses, depending on the specific product.
Rank #2
Scalp EEG and an implanted clinical interface are not interchangeable. They access signals differently and are developed for different contexts. A retail EEG headband should not be presented as a substitute for an investigational implant intended to help a person with severe motor impairment communicate or control a computer.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →How to compare BCI companies without picking a misleading “winner”
- Signal access: Is the system endovascular, placed on the cortical surface, implanted within brain tissue, designed as a retinal prosthesis, or worn on the scalp?
- Intended task: Is it aimed at communication, computer control, movement, vision restoration, research, or consumer wellness?
- Evidence and stage: Is the claim based on a company description, published research, a clinical study milestone, a regulatory statement about a specific component or use, or a commercial launch in a named region?
- Availability: Can a patient or consumer obtain it now, and where? A study authorization or an early feasibility implant does not establish retail availability.
These distinctions matter more than a single headline number. Channel counts, company-reported scale and funding do not establish that one BCI is safer, more effective or better suited to a particular person than another. The available information here does not provide a common independent performance measure across these companies.
Rank #3
What this means for someone looking for a BCI
If you are seeking an assistive communication or computer-control option for a person with paralysis, distinguish established assistive technologies from experimental BCI research and ask a qualified clinical team about suitable options and study eligibility. The companies named here are not all offering patient-ready systems. If you are shopping for consumer neurotechnology, check what a particular EEG product measures and what its maker claims it can do; do not infer medical or implant-like capability from the term “brain-computer interface.”
Quick Recap
Best Value
- Learn about your brainwaves, train your meditation, and develop your own applications with the mindwave mobile wireless headset.
- Bt/ble Dual mode module and support iOS, Android, PC, and Mac platform. Detects raw-brainwaves, eeg power spectrums (Alpha, beta, etc.), esense meters for attention, meditation, and future algorithms.
- More than 100 brain training games and educational apps available from the NeuroSky online store. Uses a single AAA battery (not included) for 8-hour battery run time
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
